ArticleCureus2025
Daily Energy Drink Intake and Arrhythmia Resistant to Direct Current Cardioversion.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Supraventricular tachycardia (SVT) is a common arrhythmia, often responsive to pharmacologic intervention or electrical cardioversion. Resistance to direct current cardioversion (DCCV) is uncommon and can be clinically challenging. Lifestyle factors, including dietary stimulant intake, may influence arrhythmia dynamics and treatment responsiveness. We present a case of a 26-year-old female known to have SVT, who presented with six hours of palpitations, with a past medical history of successful cryoablation performed in 2021 for atrial tachycardia originating from tissue near the atrioventricular bundle. Her maintenance therapy included bisoprolol 2.5 mg. Notably, the patient reported regular and excessive consumption of energy drinks, averaging multiple servings daily. The pharmacological intervention failed to achieve rhythm control, necessitating DCCV. Despite appropriate sedation and energy dosing, initial cardioversion attempts were unsuccessful. Subsequent higher-energy shocks ultimately restored sinus rhythm. This case underscores an unusual presentation of cardioversion-resistant SVT in a young adult with prior ablation. The patient's habitual intake of energy drinks raises concern for potential pro-arrhythmic and electrophysiologic alterations induced by high caffeine and other stimulant content. While caffeine's arrhythmogenic potential is recognized, its role in altering myocardial excitability and threshold for cardioversion is not well established. This case adds to the limited literature suggesting that excessive stimulant use may contribute to treatment-resistant arrhythmic episodes. Clinicians should be aware of dietary and lifestyle factors, such as energy drink consumption, which may influence the efficacy of electrical cardioversion. Further research is warranted to elucidate the mechanisms by which stimulants impact cardioversion outcomes in patients with SVT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.